Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them: Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. Generic drugs usually cost less than a brand-name drug. Tamoxifen oral tablet is only available as a generic drug. Tamoxifen is used to treat and reduce the risk of certain types of breast cancer. Tamoxifen belongs to a group of drugs called antiestrogens. A class of drugs is a group of medications that work in a similar way. These drugs are often used to treat similar conditions. Antiestrogens work by blocking the effects of the hormone estrogen in the body. Viagra lowest price Sertraline 150 mg side effects How can i order cialis Women taking tamoxifen should be informed about the risks of endometrial. cancer, and uterine sarcomas, and any abnormal vaginal bleeding, bloody vaginal. Jan 7, 2016. You will need to be checked to determine why you are bleeding. Tamoxifen can stimulate the lining of the uterus to grow, which can result in. Feb 1, 1997. Tamoxifen is a mixed estrogen agonist/antagonist that has a. undergo annual gynecologic exams and abnormal vaginal bleeding needs to be. A woman's decision whether or not to take tamoxifen to help treat breast cancer (or prevent breast cancer) should be made carefully, weighing the benefits and risks to the medication. While the benefits of tamoxifen outweigh the risks for many breast cancer patients, serious complications have been reported in a small percentage of women on tamoxifen. These complications were noted more frequently, and sometimes exclusively, in women over the age of 50. Complications that may occur from the use of tamoxifen include the following: Endometrial cancer (cancer of the lining of the uterus): Post-menopausal women who take tamoxifen and who have not had a hysterectomy (uterus removal) are at a higher risk of developing endometrial cancer than women who are not on tamoxifen. In the NSABP's Breast Cancer Prevention Trial, endometrial cancer occurred 2.5 times more frequently in women who took tamoxifen compared to women who took a placebo (inactive pill). However, the risk of endometrial cancer is still low among women on tamoxifen: approximately 2 out of 1000 women on tamoxifen will develop endometrial cancer. Research suggests that long-term use of tamoxifen among post-menopausal women increases the chances of endometrial problems. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Increasing use of the most effective methods of contraception will reduce unintended pregnancies and their social, medical and economic consequences. Listing a study does not mean it has been evaluated by the U. The contraceptive etonogestrel implant (ENG implant) is 20 times more effective at pregnancy prevention than oral contraceptive pills, but it has bleeding side effects that make it unappealing for many women. Nearly all of the 3 million unintended pregnancies in the United States each year result from inconsistent or non-use of contraception. Tamoxifen, a selective estrogen receptor modulator (SERM) used most commonly for adjuvant treatment of breast cancer, has previously been shown to dramatically reduce bleeding in users of an older levonorgestrel-based contraceptive implant (Norplant tm). It has not been studied in newer progestin-based methods such as the ENG implant. If tamoxifen could stop bleeding in users of the ENG implant, it would give patients and physicians a valuable option for management of progestin-induced irregular bleeding. This research project will test the effectiveness of tamoxifen taken on an as-needed basis to treat abnormal bleeding in ENG implant users. Tamoxifen bleeding Bleeding while on tamoxifen, can anyone help? - Breast Cancer Care., Tamoxifen Nolvadex® OncoLink Metoprolol withdrawal symptoms Mar 6, 2017. Tamoxifen is a nonsteroidal selective estrogen receptor modulator that is used primarily for adjuvant treatment of estrogen receptor-positive. Abnormal uterine bleeding and uterine pathology in women on.. Benign and Hyperplastic Endometrial Changes Associated With.. Side Effects to Expect on Tamoxifen Breast Cancer Nalie. Feb 25, 2014. If tamoxifen could stop bleeding in users of the ENG implant, it would give patients and physicians a valuable option for management of. Tamoxifen can increase the risk of serious and life-threatening events, including uterine cancer, blood clots, and stroke. These events can be fatal. You should. Jun 24, 2015. If you are taking tamoxifen, tell your doctor about any abnormal vaginal bleeding or spotting, especially after menopause, as these are possible.